Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trial

BACKGROUND: This study aimed to evaluate whether selecting mirtazapine as the first choice for current depressive episode instead of selective serotonin reuptake inhibitors (SSRIs) reduces benzodiazepine use in patients with major depressive disorder (MDD). We concurrently examined the relationship...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Ann Gen Psychiatry
Κύριοι συγγραφείς: Hashimoto, Tasuku, Shiina, Akihiro, Hasegawa, Tadashi, Kimura, Hiroshi, Oda, Yasunori, Niitsu, Tomihisa, Ishikawa, Masatomo, Tachibana, Masumi, Muneoka, Katsumasa, Matsuki, Satoshi, Nakazato, Michiko, Iyo, Masaomi
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: BioMed Central 2016
Θέματα:
Primary Research
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5070072/
https://ncbi.nlm.nih.gov/pubmed/27777607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12991-016-0115-1
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια